Medisprudence serves both plaintiff and defense — with conflict checks on every matter. This page explains the process, the safeguards, and why bilateral service produces better analysis than serving only one side.
Medisprudence follows the analysis, not a side. This is not a marketing phrase — it is a genuine operational commitment. The analytical methodology is identical regardless of who engages us. A plaintiff attorney receiving an IME deconstruction and a defense attorney receiving a pre-submission IME quality review are getting the same seven-defect analytical framework applied by the same physician. The fact that both sides are willing to pay for it is itself the strongest credibility signal: it means the analysis is objective enough that neither side views it as advocacy.
The lawyer analogy is exact. Litigation support firms — forensic accountants, e-discovery vendors, jury consultants — routinely serve both plaintiff and defense. The analysis follows the evidence. The firm follows the analysis. What makes this work is a rigorous conflict check system that both sides can trust.
Every inquiry form — both plaintiff and defense — asks for opposing party identification. This is collected before scope confirmation.
Medisprudence checks whether any current or recent engagement involves the same matter, the same parties, or any related proceeding. This check is completed before scope is confirmed and before any records are transmitted.
Medisprudence will not serve both sides of the same matter. If a conflict is found, the second inquiry is declined with a general explanation that a conflict exists — without disclosing which party or matter created the conflict.
Every scope confirmation letter includes: "We have completed our conflict check and confirmed no current engagement with any adverse party in this matter."
A physician who only serves plaintiff teams develops blind spots about what defense teams actually do. A physician who only serves defense develops blind spots about how plaintiff attorneys build their cases. Serving both sides — under separate, conflict-screened engagements — produces a physician analyst who understands the full litigation environment from the inside, not just one side's version of it.
When Medisprudence deconstructs a defense IME for a plaintiff attorney, the analysis is informed by understanding how defense teams use those reports — because we have helped defense teams prepare them. When we review a carrier's UR process for bad faith defensibility, the analysis is informed by understanding what plaintiff attorneys look for — because we have helped them find it. This bidirectional knowledge is the analytical advantage of bilateral service.
Medisprudence does not use confidential, proprietary, or plan-specific information from any current or prior employer or client. All analysis is based on publicly available clinical guidelines and general utilization review methodology. Work product from one engagement is never shared with, disclosed to, or used in any other engagement.